- Condition: Major Depressive Disorder
Interventions: Drug: escitalopram; Drug: escitalopram
Sponsors: Seoul National University Hospital; Seoul National University Hospital; H. Lundbeck A/S
Not yet recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Lu AA21004; Drug: venlafaxine extended release
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified May 2012 - Conditions: Hyperlipidemia; Diabetes Mellitus; Metabolic Syndrome; Arterial Hypertension; Obesity
Intervention: Other: first phase insulin secretion (FPIR), Hyperinsulinemic euglycemic clamp (HEC), glucose tracer, and palmitate tracer
Sponsors: University of Aarhus; University of Aarhus; Lundbeck Foundation; Aarhus University Hospital; Vejle Hospital; Sydvestjysk Hospital; Steno Diabetes Center; University of Copenhagen
Not yet recruiting - verified April 2012 - Condition: Bipolar I Disorder
Interventions: Drug: Intramuscular (IM) Depot Aripiprazole; Drug: Intramuscular (IM) Depot Placebo
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.; H. Lundbeck A/S
Not yet recruiting - verified April 2012 - Condition: Parkinson's Disease
Interventions: Drug: rasagiline; Drug: placebo
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Conditions: Thromboembolic Events; Post-operative Bleeding
Intervention:
Sponsors: Rigshospitalet, Denmark; Rigshospitalet, Denmark
Recruiting - verified March 2012 - Condition: Acute Leukemia
Intervention: Behavioral: Health counseling and exercise
Sponsors: Universitetshospitalernes Center for Sygepleje; Universitetshospitalernes Center for Sygepleje; Novo Nordisk; Lundbeck Foundation
Completed - verified March 2012 - Conditions: Postoperative Pain; Postoperative Sedation
Interventions: Drug: Gabapentin; Drug: Gabapentin; Drug: Placebo
Sponsors: Hvidovre University Hospital; Hvidovre University Hospital; Lundbeck Foundation
Recruiting - verified April 2012 - Conditions: Indolent Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia
Interventions: Drug: Bendamustine; Drug: Bendamustine
Sponsors: Lundbeck Canada Inc.; Lundbeck Canada Inc.
Recruiting - verified May 2012 - Conditions: Borderline Personality Disorder; Suicide
Interventions: Behavioral: DBT; Behavioral: CAMS
Sponsors: Mental Health Services in the Capital Region, Denmark; Mental Health Services in the Capital Region, Denmark; Lundbeck Foundation; University of Copenhagen
Recruiting - verified January 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Lu AA21004; Drug: agomelatine
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Conditions: Depressive Disorder; Anxiety Disorder
Interventions: Drug: Lu AA21004; Drug: Lu AA21004; Drug: Lu AA21004; Drug: Lu AA21004
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Condition: Parkinson's Disease
Interventions: Drug: rasagiline; Drug: placebo
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Condition: Migraine Without Aura
Interventions: Drug: Pituitary Adenylate Cyclase-Activating Polypeptide-38; Drug: Vasoactive Intestinal Peptide
Sponsors: Glostrup University Hospital, Copenhagen; Glostrup University Hospital, Copenhagen; Bispebjerg Hospital; University Hospital, Gentofte, Copenhagen; Lundbeck Foundation; Cool Sorption Foundation of 1988
Recruiting - verified November 2011 - Condition: Septic Shock
Intervention: Procedure: Mild Induced Hypothermia
Sponsors: Danish Procalcitonin Study Group; Danish Procalcitonin Study Group; TRYG Foundation; Lundbeck Foundation
Recruiting - verified April 2012 - Condition: Huntington's Disease
Intervention:
Sponsors: Ohio State University; Ohio State University; Lundbeck LLC
Recruiting - verified November 2011 - Condition: Advanced Cancer
Intervention: Other: Palliative homecare nursing
Sponsors: Bispebjerg Hospital; Bispebjerg Hospital; Danish Cancer Society; Lundbeck Foundation; Helsefonden; The Novo Nordic Foundation; Danish Nurses Organization
Recruiting - verified January 2012 - Conditions: Inflammation; Glucose Metabolism Disorders
Interventions: Biological: TNF-alpha; Biological: Endotoxin
Sponsors: Aarhus University Hospital; Aarhus University Hospital; University of Aarhus; Lundbeck Foundation
Recruiting - verified October 2011 - Conditions: Obesity; Insulin Resistance
Interventions: Dietary Supplement: Lactobacillus paracasei ssp paracasei F19; Dietary Supplement: Flax seed fibres; Dietary Supplement: Maltodextrin (Placebo)
Sponsors: University of Copenhagen; University of Copenhagen; Lundbeck Foundation; Arla Foods
Active, not recruiting - verified April 2012 - Condition: Postoperative Pain
Interventions: Drug: Escitalopram; Drug: Placebo
Sponsors: Hvidovre University Hospital; Hvidovre University Hospital; Lundbeck Foundation
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Intervention:
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Placebo; Drug: Lu AA21004 10 mg; Drug: Lu AA21004 10 mg; Drug: Lu AA21004 20 mg
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Condition: Resistant Major Depression
Intervention: Device: transcranial Direct Current Stimulation (tDCS)
Sponsors: Centre Hospitalier Universitaire de Besancon; Emmanuel Haffen; H. Lundbeck A/S
Recruiting - verified September 2011 - Condition: Healthy
Interventions: Drug: Escitalopram; Drug: Escitalopram; Drug: Escitalopram
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Completed - verified July 2011 - Condition: Epilepsy
Intervention: Drug: Anti-epileptic drug (AED)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Conditions: Kidney Transplantation; Delayed Graft Function; Acute Kidney Injury; Glomerular Filtration Rate
Intervention: Other: Remote ischemic conditioning
Sponsors: University of Aarhus; University of Aarhus; Sahlgrenska University Hospital, Sweden; Lundbeck Foundation; Novo Nordisk
Recruiting - verified March 2012 - Condition: Schizophrenia
Interventions: Drug: Zicronapine; Drug: Zicronapine; Drug: Zicronapine; Drug: Zicronapine
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Completed - verified February 2012 - Condition: Infantile Spasms
Intervention: Drug: Vigabatrin
Sponsors: Lundbeck LLC; Lundbeck LLC
Not yet recruiting - verified May 2012
 |
H. Lundbeck - Database of Clinical Trials by Pharmaceutical Companies |
